295 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
Clinical Trials of SGLT2 ... ASCVD; signal for SGLT2i ... risk; signal for SGLT2i ... outcomes trial in SGLT2i ... mcclaffertyMD #SGLT2
Definitions of AKI, CKD, AKD
Acute Kidney Injury (AKI):
 • Increase in SCr by 2 50% within
Definitions of AKI, CKD ... Chronic Kidney Disease ... (CKD): • GFR ... Acute Kidney Diseases ... months No Kidney Disease
Patient factors influencing the selection Of glucose-lowering drugs Other than SGLT2i and metformin in T2D and
drugs Other than SGLT2i ... cardiovascular disease ... : CKD. chronic ... kidney disease, ... receptor agonist SGLT2i
Gout Management in CKD
 • Colchicine
 • NSAID
 • Glucocorticoid
 • ACTH
 • Interleukin-1 Inhibitors

#Gout #Management
Management in CKD ... Gout #Management #CKD ... #rheumatology #
Expected DAT Results in Autoimmune Hemolysis
DAT Negative Hemolysis
 • DAT Poly ( - ), IgG (
), IgG ( - ), C3d ... ), IgG ( + ), C3d ... Cold agglutinin disease ... ), IgG ( - ), C3d ... Autoimmune #Hemolysis #hematology
Pathophysiology - Pathogenesis of Chronic Kidney Disease

#Pathophysiology #Nephrology #Chronic #Kidney #Disease #CKD
Chronic Kidney Disease ... Chronic #Kidney #Disease ... #CKD
Chronic kidney disease 
#ckd #chronic_kidney_disease
Chronic kidney disease ... #ckd #chronic_kidney_disease
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
-4 inhibitors SGLT2 ... Improved outcomes in CKD
Metformin Treatment in Patients With Type 2 Diabetes and Chronic Kidney Disease Stages 3A, 3B, or
Chronic Kidney Disease ... #Metformin #CKD3 ... #CKD4 #Dosing #
Approaches to Evaluating Kidney Disease in Patients with HIV Infection #Pathophys #Nephro #IM #HIV #CKD #AKI
Evaluating Kidney Disease ... Nephro #IM #HIV #CKD